Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 987 | 1127 | 1148 | 1304 | 1319 | 1485 |
Fund Return | -1.28% | 12.66% | 14.82% | 9.25% | 5.69% | 4.04% |
Place in category | 215 | 133 | 6 | 33 | 161 | 72 |
% in Category | 57 | 38 | 2 | 10 | 51 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Brandes International Equity I | 811.19M | 11.48 | 9.84 | 6.12 | ||
Brandes International Small Cap EqI | 584.91M | 23.34 | 15.01 | 7.85 | ||
Brandes Emerging Markets Value I | 487.08M | 7.71 | 3.53 | 1.70 | ||
Brandes Emerging Markets Value A | 164.18M | -5.07 | 0.44 | 1.13 | ||
Brandes International Small Cap Equ | 78.27M | -1.68 | 13.65 | 5.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 39.84B | 8.75 | 5.16 | 4.54 | ||
Fidelity Series International VVV | 14.98B | 10.37 | 7.59 | 5.74 | ||
Vanguard International Value Inv | 13.97B | 4.98 | 2.27 | 4.43 | ||
Causeway International Value Instl | 10.35B | 6.85 | 8.13 | 5.56 | ||
DFA International Value I | 8.8B | 9.09 | 7.07 | 5.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Takeda Pharmaceutical | JP3463000004 | 3.31 | 4,213.0 | +0.29% | |
Rolls-Royce Holdings | GB00B63H8491 | 3.00 | 545.60 | -2.15% | |
Heineken | NL0000008977 | 2.57 | 61.35 | -0.24% | |
Alibaba | KYG017191142 | 2.53 | 87.95 | -2.87% | |
Sanofi | FR0000120578 | 2.53 | 94.14 | +0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review